2,821
Views
8
CrossRef citations to date
0
Altmetric
Coronaviruses

One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization

, , , , , , , , ORCID Icon, , , , & ORCID Icon show all
Pages 2016-2029 | Received 18 May 2021, Accepted 12 Oct 2021, Published online: 31 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (8)